Literature DB >> 24503711

Low hip bone mineral density predicts mortality in maintenance hemodialysis patients: a five-year follow-up study.

Sinee Disthabanchong1, Sutipong Jongjirasiri, Surawat Adirekkiat, Vasant Sumethkul, Atiporn Ingsathit, Somnuek Domrongkitchaiporn, Bunyong Phakdeekitcharoen, Surasak Kantachuvesiri, Chagriya Kitiyakara.   

Abstract

BACKGROUND: Bone loss is common among hemodialysis patients and contributes to mortality. The association between bone loss and vascular calcification may explain the increased mortality risk. Studies on the association between decreased bone mass and mortality in maintenance hemodialysis patients are limited.
METHODS: Eighty-three hemodialysis patients underwent bone mineral density (BMD) and coronary artery calcification (CAC) measurements. The relationship between BMD and mortality was analyzed after a 5-year follow-up period.
RESULTS: Eighty percent of the patients had reduced hip BMD. In univariate Cox regression analyses, age, cardiovascular disease, dyslipidemia, increased CAC score, increased comorbidity score and decreased hip BMD were associated with mortality. Low hip BMD remained independently associated with mortality after adjustments for cardiovascular risk factors, comorbidity score and CAC score. Patients with BMD in the lowest tertile had the worst survival.
CONCLUSION: Low hip BMD predicted mortality in maintenance hemodialysis patients independent of CAC.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24503711     DOI: 10.1159/000357639

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality.

Authors:  Ken Iseri; Abdul Rashid Qureshi; Jonaz Ripsweden; Olof Heimbürger; Peter Barany; Ingrid B Bergström; Peter Stenvinkel; Torkel B Brismar; Bengt Lindholm
Journal:  J Bone Miner Metab       Date:  2020-09-04       Impact factor: 2.626

Review 2.  Mineral and bone disorder after kidney transplantation.

Authors:  Pahnwat T Taweesedt; Sinee Disthabanchong
Journal:  World J Transplant       Date:  2015-12-24

3.  Bone Mineral Density of the Radius Predicts All-Cause Mortality in Patients With Type 2 Diabetes: Diabetes Heart Study.

Authors:  Leon Lenchik; Thomas C Register; Fang-Chi Hsu; Jianzhao Xu; S Carrie Smith; J Jeffrey Carr; Barry I Freedman; Donald W Bowden
Journal:  J Clin Densitom       Date:  2017-12-01       Impact factor: 2.617

4.  Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients.

Authors:  Zhimin Chen; Jia Sun; Mathias Haarhaus; Peter Barany; Lars Wennberg; Jonaz Ripsweden; Torkel B Brismar; Bengt Lindholm; Annika Wernerson; Magnus Söderberg; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  J Bone Miner Metab       Date:  2016-12-02       Impact factor: 2.626

5.  Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study.

Authors:  David A Jaques; Scott Henderson; Andrew Davenport
Journal:  Clin Kidney J       Date:  2022-01-31

6.  Forearm bone mass predicts mortality in chronic hemodialysis patients.

Authors:  Lidija Orlic; Ivana Mikolasevic; Zeljka Crncevic-Orlic; Ivan Jakopcic; Josipa Josipovic; Drasko Pavlovic
Journal:  J Bone Miner Metab       Date:  2016-07-27       Impact factor: 2.626

Review 7.  Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease.

Authors:  Sinee Disthabanchong; Sarinya Boongird
Journal:  World J Nephrol       Date:  2017-05-06

8.  Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism.

Authors:  Li Fang; Jining Wu; Jing Luo; Ping Wen; Mingxia Xiong; Jinlong Cao; Xiaolan Chen; Junwei Yang
Journal:  BMC Nephrol       Date:  2018-06-15       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.